← Evidence map

ArticleScientific reports2026

Integrating network pharmacology with ex-vivo analysis to assess the effect of IL-2 in halting breast cancer: involvement of Treg/CTLA-4/Blimp-1/caspase-3.

Seham Abou Shousha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Integrating network pharmacology with ex-vivo analysis to assess the effect of IL-2 in halting breast cancer: involvement of Treg/CTLA-4/Blimp-1/caspase-3. | OpenQuestion